MedTrace Logo

Low Contrast Agent and Radiation Dose Protocol for Liver CT in Patients With HCC

NCT04722120 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 68

Last updated 2022-02-14

No results posted yet for this study

Summary

The purpose of this study is to investigate the image quality and clinical feasibility of double low-dose liver computed tomography using a deep-learning-based iodine contrast boosting algorithm in participants at high risk for hepatocellular carcinoma.

Conditions

Interventions

RADIATION

Low radiation dose CT

Underwent liver CT with 30% lower radiation dose

RADIATION

Conventional CT (radiation)

Underwent liver CT without change of radiation.

DRUG

Low contrast dose CT

Underwent liver CT 20% lower dose contrast media.

DRUG

Conventional CT (contrast agent)

Underwent liver CT without change of contrast media doses.

OTHER

Deep-learning based contrast boosting algorithms

Applied deep-learning based contrast boosting algorithms on acquired CT images

Sponsors & Collaborators

  • Seoul National University Hospital

    lead OTHER

Principal Investigators

  • Jeong Min Lee, MD · Seoul National University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-06-01
Primary Completion
2018-01-01
Completion
2021-01-01

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04722120 on ClinicalTrials.gov